ABSORB Japan: 2-year clinical results from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent in de novo native coronary artery lesions
Event:
ESC Congress 2016
Topic:
PCI / stents: devices and technique
Session:
Clinical Trial Update Coronary artery disease